SAN DIEGO & DORTMUND, Germany--(BUSINESS WIRE)--PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Inova Diagnostics, ...
SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is proud to announce the clearance of ...
Inova Diagnostics, the worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that the United States Food and Drug Administration (FDA) has cleared ...
Inova Diagnostics this week bagged new technology developed at Hasselt University designed to identify a more sensitive collection of biomarkers for rheumatoid arthritis, once again setting its sights ...
The positions in the table below reflect the Inova Diagnostics's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...
SAN DIEGO, Aug. 14, 2018 /PRNewswire/ -- Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is ...
Protagen AG and Inova Diagnostics have signed a semi-exclusive license agreement for BICD2, a novel autoantigen and the first proprietary biomarker discovered by Protagen employing its SeroTag ...
Protagen AG and Inova Diagnostics have signed a semi-exclusive license agreement for BICD2, a novel autoantigen and the first proprietary biomarker discovered by Protagen employing its SeroTag® ...
San Diego-based INOVA Diagnostics, a developer of medical diagnostic tests for autoimmune diseases, has been acquired by Barcelona, Spain-based Werfen Group S.A. Werfen did not disclose financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results